Table 2.
Descriptive Statistics for the MDASI-BT Module Test
| MDASI-BT module | Mean | SD | Range | LCL | UCL | % = 0a | % 1-4b | % ≥5c | % ≥7d | % Missinge |
|---|---|---|---|---|---|---|---|---|---|---|
| Core symptoms (rank order) | ||||||||||
| Fatigue | 4.92 | 2.90 | 10 | 4.56 | 5.28 | 8.6 | 30.5 | 60.9 | 39.0 | 0.0 |
| Distress | 4.21 | 2.98 | 10 | 3.84 | 4.58 | 14.3 | 35.2 | 49.6 | 26.9 | 0.01 |
| Drowsiness | 4.01 | 3.18 | 10 | 3.62 | 4.41 | 14.3 | 43.8 | 41.9 | 25.7 | 0.0 |
| Sadness | 3.55 | 3.17 | 10 | 3.16 | 3.94 | 23.8 | 35.2 | 39.0 | 27.6 | 0.02 |
| Sleep disturbance | 3.48 | 3.64 | 10 | 3.05 | 3.91 | 33.3 | 30.5 | 35.3 | 26.7 | 0.01 |
| Problem with remembering things | 3.40 | 2.80 | 9 | 3.05 | 3.75 | 21.9 | 44.8 | 33.4 | 21.0 | 0.0 |
| Dry mouth | 3.03 | 3.11 | 10 | 2.65 | 3.42 | 36.2 | 29.5 | 32.3 | 17.1 | 0.02 |
| Pain | 2.98 | 3.09 | 10 | 2.59 | 3.36 | 32.4 | 34.3 | 33.3 | 19.0 | 0.0 |
| Lack of appetite | 1.90 | 2.87 | 10 | 1.54 | 2.25 | 54.3 | 25.7 | 20.0 | 14.3 | 0.0 |
| Numbness or tingling | 1.70 | 2.52 | 10 | 1.39 | 2.01 | 54.3 | 29.5 | 16.2 | 7.6 | 0.0 |
| Nausea | 1.66 | 3.10 | 10 | 1.27 | 2.04 | 62.9 | 19.0 | 18.1 | 12.4 | 0.0 |
| Shortness of breath | 1.30 | 2.22 | 10 | 1.02 | 1.57 | 62.9 | 27.6 | 9.5 | 3.8 | 0.0 |
| Vomiting | 1.09 | 2.70 | 10 | 0.76 | 1.43 | 78.1 | 6.7 | 14.3 | 9.5 | 0.01 |
| Module items (rank order) | ||||||||||
| Difficulty concentrating | 3.10 | 2.81 | 10 | 2.75 | 3.45 | 24.8 | 47.6 | 25.7 | 13.3 | 0.02 |
| Irritability | 2.91 | 2.71 | 10 | 2.57 | 3.24 | 26.7 | 47.6 | 23.8 | 14.3 | 0.02 |
| Difficulty speaking | 2.59 | 2.94 | 10 | 2.22 | 2.95 | 40.0 | 38.1 | 21.0 | 16.3 | 0.01 |
| Appearance | 2.38 | 2.91 | 10 | 2.02 | 2.74 | 36.2 | 38.1 | 22.8 | 13.3 | 0.03 |
| Weakness | 2.29 | 3.24 | 10 | 1.89 | 2.69 | 52.4 | 20.0 | 27.6 | 19.0 | 0.0 |
| Difficulty understanding | 2.15 | 2.54 | 10 | 1.83 | 2.46 | 41.0 | 41.9 | 15.3 | 8.6 | 0.02 |
| Vision | 2.18 | 2.94 | 10 | 1.82 | 2.55 | 48.6 | 27.6 | 21.0 | 12.4 | 0.03 |
| Change in bowel pattern | 2.09 | 2.70 | 9 | 1.76 | 2.43 | 48.6 | 27.6 | 22.8 | 13.3 | 0.01 |
| Seizures | 0.40 | 1.57 | 8 | 0.21 | 0.60 | 89.5 | 2.9 | 4.8 | 3.8 | 0.03 |
| Interference items (rank order) | ||||||||||
| Work, including housework | 4.77 | 3.76 | 10 | 4.30 | 5.24 | 21.0 | 25.7 | 53.3 | 43.8 | 0.0 |
| General activity | 4.75 | 3.25 | 10 | 4.34 | 5.15 | 14.3 | 32.4 | 52.3 | 37.1 | 0.01 |
| Mood | 3.53 | 2.66 | 10 | 3.20 | 3.86 | 13.3 | 46.7 | 37.1 | 18.1 | 0.03 |
| Relations with other people | 2.71 | 2.95 | 10 | 2.35 | 3.08 | 33.3 | 36.2 | 28.5 | 19.0 | 0.02 |
| Walking | 2.66 | 3.32 | 10 | 2.24 | 3.07 | 43.3 | 28.8 | 27.6 | 19.0 | 0.01 |
| Enjoyment of life | 2.36 | 2.69 | 10 | 2.02 | 2.69 | 33.3 | 41.9 | 22.9 | 12.4 | 0.02 |
| Subscale scores | ||||||||||
| Affective | 3.89 | 2.33 | 9 | 3.47 | 4.31 | |||||
| Cognitive | 2.75 | 2.34 | 10 | 2.32 | 3.17 | |||||
| Focal neurologic deficit | 1.99 | 1.47 | 5.75 | 1.72 | 2.26 | |||||
| Treatment-related | 3.10 | 2.42 | 10 | 2.66 | 3.54 | |||||
| Generalized/disease status | 2.00 | 1.67 | 7 | 1.70 | 2.31 | |||||
| Gastrointestinal | 1.47 | 2.79 | 10 | 0.97 | 1.98 | |||||
| Core items | 2.95 | 1.84 | 7.77 | 2.61 | 3.28 | |||||
| Module items | 2.24 | 1.56 | 7 | 1.96 | 2.52 | |||||
| All symptom items | 2.68 | 1.57 | 7.29 | 2.39 | 2.96 | |||||
| Mean interference (6 items) | 3.64 | 2.47 | 10 | 3.37 | 3.92 | |||||
| Mean WAW (walk-activity-work) | 4.24 | 3.12 | 10 | 3.89 | 4.59 | |||||
| Mean REM (relate-enjoy-mood) | 3.04 | 2.47 | 10 | 2.76 | 3.31 |
Abbreviations: LCL, lower 95% CL; MDASI-BT, The MD Anderson Symptom Inventory Brain Tumor Module; REM-role functioning, relations with others, enjoyment of life, and mood; UCL, upper 95% CL; WAW, walking, general activity, and work.
MDASI-BT Constructs/Subscales: Affective (distress, fatigue, disturbed sleep, sadness, irritability); Cognitive (difficulty understanding, problem with remembering things, difficulty speaking, difficulty concentrating); Focal neurologic deficit (seizures, numbness or tingling, pain, weakness). Treatment-related (dry mouth, drowsiness, lack of appetite); generalized/disease status (change in appearance, change in vision, change in bowel patterns, shortness of breath); gastrointestinal (nausea, vomiting).
aPercentage of patients scoring at the floor (score = 0 on the 0-10 scale).
bPercentage mild.
cPercentage moderate to severe.
dPercentage severe.
ePercentage of missing data.